Minicircle DNA-Engineered CAR T Cells Suppressed Tumor Growth in Mice

被引：13

作者：

Han, Jinsheng ^{[1
]}

Gao, Fei ^{[1
,2
]}

Geng, Songsong ^{[4
]}

Ye, Xueshuai ^{[1
]}

Wang, Tie ^{[3
,4
]}

Du, Pingping ^{[4
]}

Cai, Ziqi ^{[4
]}

Fu, Zexian ^{[5
]}

Zhao, Zhilong ^{[6
]}

Shi, Long ^{[7
]}

Li, Qingxia ^{[2
]}

Cai, Jianhui ^{[1
,2
]}

机构：

[1] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China

[2] Hebei Gen Hosp, Dept Surg & Oncol, Shijiazhuang, Hebei, Peoples R China

[3] Hebei HOFOY Biotech Co Ltd, Hebei Engn Technol Res Ctr Cell Therapy, Shijiazhuang, Hebei, Peoples R China

[4] Hebei Cangzhou Hosp Integrated Tradit Chinese & W, Dept Surg, Cangzhou, Hebei, Peoples R China

[5] Hebei Engn Univ, Dept Surg, Affiliated Hosp, Handan, Hebei, Peoples R China

[6] Jinzhou Med Univ, Dept Surg, Affiliated Hosp 3, Jinzhou, Liaoning, Peoples R China

[7] Hebei Med Univ, Dept Oncol, Hosp 2, Shijiazhuang, Hebei, Peoples R China

来源：

MOLECULAR CANCER THERAPEUTICS | 2020年 / 19卷 / 01期

关键词：

CHIMERIC ANTIGEN RECEPTOR; EXPRESSION; VECTOR; TRANSPOSON; THERAPY;

D O I：

10.1158/1535-7163.MCT-19-0204

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Viral-based chimeric antigen receptor-engineered T (CAR T)-cell manufacturing has potential safety risks and relatively high costs. The nonviral minicircle DNA (mcDNA) is safer for patients, cheaper to produce, and may be a more suitable technique to generate CAR T cells. In this study, we produced mcDNA-based CAR T cells specifically targeting prostate stem cell antigen (PSCA; mcDNA-PSCA-CAR T cells). Our results showed that mcDNA-PSCA-CAR T cells persisted in mouse peripheral blood as long as 28 days and demonstrated more CAR T-cell infiltration, higher cytokine secretion levels, and better antitumor effects. Together, our results suggest that mcDNA-CAR can be a safe and cost-effective platform to produce CAR T cells.

引用

页码：178 / 186

页数：9

共 50 条

[1] Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo
Wang, Hezhi
Ye, Xueshuai
Ju, Yi
Cai, Ziqi
Wang, Xiaoxiao
Du, Pingping
Zhang, Mengya
Li, Yang
Cai, Jianhui
ONCOTARGETS AND THERAPY, 2020, 13 : 3703 - 3716
[2] Selective depletion of regulatory T cells suppressed neuroblastoma tumor growth in mice
von Lenthe, Sophie
Weissenborn, Christine
Zenclussen, Ana Claudia
Fest, Stefan
Metelitsa, Leonid
CANCER RESEARCH, 2019, 79 (13)
[3] DNA-Engineered Degradable Invisibility Cloaking for Tumor-Targeting Nanoparticles
Zhao, Yan
Hou, Junjun
Guo, Linjie
Zhu, Shitai
Hou, Xiaoling
Cao, Shuting
Zhou, Mo
Shi, Jiye
Li, Jiang
Liu, Kai
Zhang, Hongjie
Wang, Lihua
Fan, Chunhai
Zhu, Ying
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2024, 146 (36) : 25253 - 25262
[4] Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
Victoria Hillerdal
Mohanraj Ramachandran
Justyna Leja
Magnus Essand
BMC Cancer, 14
[5] Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
Hillerdal, Victoria
Ramachandran, Mohanraj
Leja, Justyna
Essand, Magnus
BMC CANCER, 2014, 14
[6] Simultaneous imaging of cancer biomarkers in live cells based on DNA-engineered exosomes
Chen, Meng-Li
He, Fang
Yin, Bin-Cheng
Ye, Bang-Ce
ANALYST, 2021, 146 (05) : 1626 - 1632
[7] Engineered Hypoimmune CAR T Cells Provide Lasting Tumor Control in Fully Immunocompetent Allogeneic Humanized Mice
Hu, Xiaomeng
Beauchesne, Pascal
Manner, Karl
Gattis, Corie
Ngo, Priscilla
De Jesus, Rowena
Young, Chi
Wells, Frank
Weng, Lindong
White, Kathy
Dowdle, William E.
Foster, Aaron
Fry, Terry
Schrepfer, Sonja
BLOOD, 2022, 140 : 1173 - 1175
[8] Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia
Ye, Xueshuai
Wu, Yongqiang
Zhang, c Haiqiang
Shi, de Long
Zhou, Ye
Guo, Sumin
Dong, Jiantao
Cai, Jianhui
CANCER LETTERS, 2023, 568
[9] Bacteria-free minicircle DNA system to generate integration-free CAR-T cells
Cheng, Chen
Tang, Na
Li, Jiaxin
Cao, Shiwei
Zhang, Tongtong
Wei, Xiaofei
Wang, Haoyi
JOURNAL OF MEDICAL GENETICS, 2019, 56 (01) : 10 - 17
[10] Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo (vol 13, pg 3703, 2020)
Wang, H.
Ye, X.
Ju, Y.
ONCOTARGETS AND THERAPY, 2020, 13 : 5707 - 5707

← 1 2 3 4 5 →